---
id: 84
registrationType: 境外生产药品
genericName: 达比加群
productName: 达比加群酯胶囊
productNameEn: Dabigatran Etexilate Capsules
brandName: 泰毕全
brandNameEn: Pradaxa
category: 化学药品
formulation: 胶囊剂
specification: 110mg
registrationNumber: 国药准字HJ20210078
mahName: Boehringer Ingelheim International GmbH
mahAddress: Binger Strasse 173, 55216 Ingelheim am Rhein, Germany
manufacturerName: Boehringer Ingelheim Pharma GmbH & Co. KG
manufacturerAddress: Binger Strasse 173, 55216 Ingelheim am Rhein, Germany
manufacturerCountry: 德国
packagingName: 勃林格殷格翰（中国）投资有限公司
packagingAddress: 上海市浦东新区外高桥保税区基隆路18号
approvalDate: 2021-03-30
isOriginal: true
originator: Boehringer Ingelheim
originatorSource:
  - type: FDA橙皮书
    url: https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=022512
  - type: 企业年报
    url: https://www.boehringer-ingelheim.com/about-us/corporate-profile
originalException: "原研企业授权上海工厂分装"
---

## 适应症

1. 预防非瓣膜性房颤患者的卒中和全身性栓塞
2. 治疗深静脉血栓和肺栓塞
3. 预防深静脉血栓和肺栓塞复发
4. 关节置换术后预防静脉血栓栓塞

## 注意事项

1. 出血风险评估
2. 监测凝血功能
3. 肾功能不全需调整剂量
4. 胶囊不可打开服用

## 不良反应

- 出血
- 消化道不适
- 贫血
- 腹痛
- 胃食管反流 